User profiles for MR Barer

Michael R Barer

Professor of Clinical Microbiology, University of Leicester
Verified email at le.ac.uk
Cited by 12384

Viability and activity in readily culturable bacteria: a review and discussion of the practical issues

…, DH Weichart, CR Harwood, MR Barer - Antonie Van …, 1998 - Springer
In microbiology the terms ‘viability’ and ‘culturability’ are often equated. However, in recent
years the apparently self-contradictory expression ‘viable-but-nonculturable’ (‘VBNC’) has …

Bacterial viability and culturability

MR Barer, CR Harwood - Advances in microbial physiology, 1999 - Elsevier
… Smith and MR Barer, unpublished observations), although we have not been able to
exclude the possibility that limited replication occurs in the absence of the quinolone. Further, if …

Targeting persisters for tuberculosis control

Y Zhang, WW Yew, MR Barer - Antimicrobial agents and …, 2012 - Am Soc Microbiol
Mycobacterial persisters, the survivors from antibiotic exposure, necessitate the lengthy
treatment of tuberculosis (TB) and pose a significant challenge for our control of the disease. We …

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers

…, RH Green, P Venge, DA Lomas, MR Barer… - American journal of …, 2011 - atsjournals.org
Rationale: Exacerbations of chronic obstructive pulmonary disease (COPD) are heterogeneous
with respect to inflammation and etiology. Objectives: Investigate biomarker expression …

[BOOK][B] Medical microbiology e-book: A guide to microbial infections: Pathogenesis, immunity, laboratory diagnosis and control. with STUDENT CONSULT online …

D Greenwood, RCB Slack, MR Barer, WL Irving - 2012 - books.google.com
Medical microbiology concerns the nature, distribution and activities of microbes and how
they impact on health and wellbeing, most particularly as agents of infection. Infections remain …

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial

…, P Venge, DA Lomas, MR Barer… - American journal of …, 2012 - atsjournals.org
Rationale: Exacerbations of chronic obstructive pulmonary disease (COPD) and responses
to treatment are heterogeneous. Objectives: Investigate the usefulness of blood eosinophils …

[HTML][HTML] Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum

…, RA Adegbola, GS Besra, PD Butcher, MR Barer - PLoS …, 2008 - journals.plos.org
Background Tuberculous sputum provides a sample of bacilli that must be eliminated by
chemotherapy and that may go on to transmit infection. A preliminary observation that …

Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response.

PT Kimmitt, CR Harwood, MR Barer - Emerging infectious diseases, 2000 - ncbi.nlm.nih.gov
… norfloxacin (13), and we have made similar observations with ofloxacin and trimethoprim
(Kimmit, Harwood and Barer, unpubl data). Moreover, sequencing studies clearly indicate that …

Lung microbiome dynamics in COPD exacerbations

…, SL Johnston, MY Ramsheh, MR Barer… - European …, 2016 - Eur Respiratory Soc
Increasing evidence suggests that the lung microbiome plays an important role in chronic
obstructive pulmonary disease (COPD) severity. However, the dynamics of the lung …

Characterization of the bacterial consortium associated with black band disease in coral using molecular microbiological techniques

…, O Pantos, MDAL Tissier, MR Barer… - Environmental …, 2002 - Wiley Online Library
The bacterial community associated with black band disease (BBD) of the scleractinian
corals Diploria strigosa, Montastrea annularis and Colpophyllia natans was examined using …